Complement weight management programs : Enhances results when paired with healthy diet and exercise
Certain factors may increase the likelihood of experiencing bloating on GLP-1 therapy, including: Pre-existing gastrointestinal conditions such as irritable bowel syndrome (IBS), functional dyspepsia, or small intestinal bacterial overgrowth (SIBO) Rapid dose escalation without adequate titration periods Dietary factors , particularly high intake of fermentable carbohydrates (FODMAPs), fatty foods, or carbonated beverages Concurrent medications that affect gastrointestinal motility Patients should be aware that GLP-1 receptor agonists have been associated with more serious gastrointestinal adverse effects, including pancreatitis (inflammation of the pancreas) and gallbladder disease
Upcoming Insurance Changes for GLP-1 Medications: What You Need to Know Aug 4, 2025 2 min read At MFM Health, your care and well-being are always our top priority
Gallbladder Issues: Including rare events like gallstones or inflammation
42 Lunges: Works thighs and glutes, challenges balance
